Moreover, survival data from the Kaplan–Meier plotter demonstrated that BC patients with high CCL17/18/24 mRNA levels and low CCL3/4/15/19/21/22 mRNA levels were significantly associated with worse OS (Figure 4, Table 2, all P<0.05). Here, CCL17 is linked to breast cancer.